First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sees Large Volume Increase

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) shares saw strong trading volume on Monday . 73,004 shares traded hands during trading, an increase of 182% from the previous session’s volume of 25,887 shares.The stock last traded at $171.67 and had previously closed at $170.92.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 0.1 %

The stock has a market capitalization of $1.30 billion, a P/E ratio of 17.20 and a beta of 0.86. The company has a fifty day simple moving average of $166.14 and a two-hundred day simple moving average of $156.38.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

A number of institutional investors and hedge funds have recently modified their holdings of FBT. Principal Securities Inc. acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter worth $32,000. Avantax Advisory Services Inc. raised its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 37.0% during the fourth quarter. Avantax Advisory Services Inc. now owns 3,397 shares of the company’s stock worth $537,000 after purchasing an additional 917 shares during the period. Level Four Advisory Services LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter valued at about $524,000. Assetmark Inc. grew its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 165.1% in the 4th quarter. Assetmark Inc. now owns 5,994 shares of the company’s stock valued at $947,000 after purchasing an additional 3,733 shares during the period. Finally, Jones Financial Companies Lllp bought a new stake in First Trust NYSE Arca Biotechnology Index Fund during the 4th quarter worth approximately $201,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.